本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

9.87
-0.3200-3.14%
盤前9.990.1200+1.22%07:56 EDT
成交量:340.57萬
成交額:3,418.63萬
市值:21.61億
市盈率:-6.98
高:10.32
開:10.21
低:9.81
收:10.19
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:1.47
換手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.15
市盈率(LYR):-6.95

資料載入中...

2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/05

重要事件披露

Form 8-K - Current report
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/05

重要事件披露

Form 8-K - Current report
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities